Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments
-- Recorded First Quarter Revenue of $36.7 Million -- -- Signed $41 Million in Net New Business Orders and Ended the Quarter with a Record High Backlog of $157 Million -- -- Facilities and Capabilities Expansions in Mammalian and Cell and Gene Therapy …